Advaxis, Incorporated


Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis’ scientific advisory board. Advaxis is developing attenuated live Lm vaccines that deliver engineered tumor antigens, which stimulate multiple simultaneous immunological mechanisms to fight cancer.

Saturday, January 9, 2010

Advaxis to Present at the Sidoti Microcap 2010 Investor Conference



Sidoti & Company, LLC is the largest and fastest-growing small-cap, equity research provider on Wall Street. The company’s analysts provide institutional-quality research on nearly 600 equities across more than 30 industries, focusing on undiscovered, profitable companies at a market capitalization below $3 billion. Sidoti research is exclusive to institutional investors; the company’s sales and trading staff serve hundreds of clients in the U.S. and Canada.

The Grand Hyatt Hotel, New York City / Monday, January 11, 2010, 11:50 AM EST
Posted by at